BIONATURIS

Trading sesion


17/01/2018 Close

3.0000

Last price


13.64 mill. €

Capitalisation

11.94

Dif.(%)


-10.07

% Year 2018

Last Trade

Last

3.0000

Ref.

2.6800

Dif.(%)

11.94

Volume (Shares)

15,021

Turnover (€x1000)

44.06

Security

Security name

BIONATURIS (BIOORGANIC RESEARCH SERV.)

Ticker

BNT

ISIN

ES0184980003

NIF

A-11811163

Capital Admitted

254.508,95 Euros

Shares Admitted

5.090.179

Nominal

0,05 Euros

Trading

Continuo

Liquidity Provider

GVC Gaesco Beka, S.V., S.A.

Registered Advisor

DCM ASESORES Dirección y Consultoría de Mercados, S.L.

Auditor

PAEZ & SERRANO AUDITORIES, S.L.U.

Address

AV DESARROLLO TECNOLOGICO 11, JEREZ DE LA FRONTERA

Contact

ir@bionaturis.com

Historical Summary

 20142015201620172018 until 16/01

Capital Admitted (thousands of euros)

232232255255255

Shares (x 1,000)

4,6334,6335,0905,0905,090

Period Close Price (euros)

7.90003.60003.11002.98002.6800

Period Last Price (euros)

7.90003.60003.11002.98002.6800

Period High Price (euros)

13.98008.20005.23003.96003.0000

Period Low Price (euros)

3.53003.59002.65001.40002.5800

Capitalisation (thousands of euros)

36,60116,67915,83015,16913,642

Volume (thousands of shares)

3,3952,13642697589

Turnover (thousands of euros)

24,84911,9571,6082,479258

Company Profile

Bionaturis is a biotechnology-based group offering premium solutions for human and animal health applications. The Biotech Group comprises 4 companies (Bionaturis, Biobide, ZIP Solutions, and BNT Pacific LTD) and 2 subsidiaries (BNT China Biosciences and Biobide USA) located in three different continents, being worldwide references in their markets.

The matrix company of the Group, Bionaturis -Jerez de la Frontera, Cadiz-, is devoted to Animal Health, where is positioned as a partner of choice to bring high profitable products and services to the market place. By a B2B business model Bionaturis co-develops best-in-class prescription and non-prescription products for food production animals (FPAs) and pets. Cutting-edge antigens, probiotics and feed additives, among others, are part of the broad portfolio of products to meet the main needs of a steady growing sector.

Biobide -San Sebastian- is a preclinical CRO (Contract Research Organization) worldwide leader in the use of zebrafish as animal model for efficacy and toxicity assays for the Pharma, cosmetic, nutraceutical, agri-food, and environmental sectors.

ZIP Solutions –Barcelona- is a leading company in bioprocess having a relevant portfolio of international patents around its two main assets: Splittera and Zera Vaccines (subunit 2.0 and DNA vaccines). Its business model is based on the license of its proprietary systems to tier 1 companies in the sector.

Relevant Facts and Notices

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.

MARKET STATUS

If an issue occurs, the message "TRADING" will change to "MARKET ISSUE" to reflect that a market event has occurred. By clicking on the Issue of the published alert it will be possible to access the information and intraday updates associated with this incident, which will be published immediately.

Note: BME will use its discretion to assign the severity of an incident